NCT02629705View on ClinicalTrials.gov

Study of Carrageenan's Effect on Insulin Resistance in Humans

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 23, 2016

Study Completion Date

February 28, 2018

Conditions
Diabetes Mellitus, Type 2Insulin Resistance
Interventions
DIETARY_SUPPLEMENT

Carrageenan

Carrageenan 250 mg bid supplemented to a standard food

DIETARY_SUPPLEMENT

Placebo

Placebo (Mannitol/Aerosil) bid supplemented to a standard food

Trial Locations (1)

72076

University Hospital Tübingen, Department of Internal Medicine, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT02629705 - Study of Carrageenan's Effect on Insulin Resistance in Humans | Biotech Hunter | Biotech Hunter